BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 18854869)

  • 1. How to tackle the diagnosis of limb-girdle muscular dystrophy 2A.
    Fanin M; Nascimbeni AC; Tasca E; Angelini C
    Eur J Hum Genet; 2009 May; 17(5):598-603. PubMed ID: 18854869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of calpain-3 autolytic activity in LGMD muscle: a functional map of CAPN3 gene mutations.
    Fanin M; Nascimbeni AC; Angelini C
    J Med Genet; 2007 Jan; 44(1):38-43. PubMed ID: 16971480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular diagnosis in LGMD2A: mutation analysis or protein testing?
    Fanin M; Fulizio L; Nascimbeni AC; Spinazzi M; Piluso G; Ventriglia VM; Ruzza G; Siciliano G; Trevisan CP; Politano L; Nigro V; Angelini C
    Hum Mutat; 2004 Jul; 24(1):52-62. PubMed ID: 15221789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limb girdle muscular dystrophy type 2A in India: a study based on semi-quantitative protein analysis, with clinical and histopathological correlation.
    Pathak P; Sharma MC; Sarkar C; Jha P; Suri V; Mohd H; Singh S; Bhatia R; Gulati S
    Neurol India; 2010; 58(4):549-54. PubMed ID: 20739790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational Spectrum of CAPN3 with Genotype-Phenotype Correlations in Limb Girdle Muscular Dystrophy Type 2A/R1 (LGMD2A/LGMDR1) Patients in India.
    Pathak P; Sharma MC; Jha P; Sarkar C; Faruq M; Jha P; Suri V; Bhatia R; Singh S; Gulati S; Husain M
    J Neuromuscul Dis; 2021; 8(1):125-136. PubMed ID: 33337384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein and genetic diagnosis of limb girdle muscular dystrophy type 2A: The yield and the pitfalls.
    Fanin M; Angelini C
    Muscle Nerve; 2015 Aug; 52(2):163-73. PubMed ID: 25900067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of LGMD gene mutations in Italian patients with distinct clinical phenotypes.
    Fanin M; Nascimbeni AC; Aurino S; Tasca E; Pegoraro E; Nigro V; Angelini C
    Neurology; 2009 Apr; 72(16):1432-5. PubMed ID: 19380703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. cDNA analyses of CAPN3 enhance mutation detection and reveal a low prevalence of LGMD2A patients in Denmark.
    Duno M; Sveen ML; Schwartz M; Vissing J
    Eur J Hum Genet; 2008 Aug; 16(8):935-40. PubMed ID: 18337726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the UK diagnostic strategy for limb girdle muscular dystrophy 2A.
    Groen EJ; Charlton R; Barresi R; Anderson LV; Eagle M; Hudson J; Koref MS; Straub V; Bushby KM
    Brain; 2007 Dec; 130(Pt 12):3237-49. PubMed ID: 18055493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of novel CAPN3 isoforms in white blood cells: an alternative approach for limb-girdle muscular dystrophy 2A diagnosis.
    Blázquez L; Azpitarte M; Sáenz A; Goicoechea M; Otaegui D; Ferrer X; Illa I; Gutierrez-Rivas E; Vilchez JJ; López de Munain A
    Neurogenetics; 2008 Jul; 9(3):173-82. PubMed ID: 18563459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A heterozygous 21-bp deletion in CAPN3 causes dominantly inherited limb girdle muscular dystrophy.
    Vissing J; Barresi R; Witting N; Van Ghelue M; Gammelgaard L; Bindoff LA; Straub V; Lochmüller H; Hudson J; Wahl CM; Arnardottir S; Dahlbom K; Jonsrud C; Duno M
    Brain; 2016 Aug; 139(Pt 8):2154-63. PubMed ID: 27259757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LGMD2A: genotype-phenotype correlations based on a large mutational survey on the calpain 3 gene.
    Sáenz A; Leturcq F; Cobo AM; Poza JJ; Ferrer X; Otaegui D; Camaño P; Urtasun M; Vílchez J; Gutiérrez-Rivas E; Emparanza J; Merlini L; Paisán C; Goicoechea M; Blázquez L; Eymard B; Lochmuller H; Walter M; Bonnemann C; Figarella-Branger D; Kaplan JC; Urtizberea JA; Martí-Massó JF; López de Munain A
    Brain; 2005 Apr; 128(Pt 4):732-42. PubMed ID: 15689361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of limb-girdle muscular dystrophy 2A by immunohistochemical techniques.
    Kolski HK; Hawkins C; Zatz M; de Paula F; Biggar D; Alman B; Vajsar J
    Neuropathology; 2008 Jun; 28(3):264-8. PubMed ID: 18031465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiological and Molecular Characterization of a Mexican Population Isolate with High Prevalence of Limb-Girdle Muscular Dystrophy Type 2A Due to a Novel Calpain-3 Mutation.
    Pantoja-Melendez CA; Miranda-Duarte A; Roque-Ramirez B; Zenteno JC
    PLoS One; 2017; 12(1):e0170280. PubMed ID: 28103310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe limb-girdle muscular dystrophy 2A in two young siblings from Guinea-Bissau associated with a novel null homozygous mutation in CAPN3 gene.
    Oliveira Santos M; Ninitas P; Conceição I
    Neuromuscul Disord; 2018 Dec; 28(12):1003-1005. PubMed ID: 30415788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extensive scanning of the calpain-3 gene broadens the spectrum of LGMD2A phenotypes.
    Piluso G; Politano L; Aurino S; Fanin M; Ricci E; Ventriglia VM; Belsito A; Totaro A; Saccone V; Topaloglu H; Nascimbeni AC; Fulizio L; Broccolini A; Canki-Klain N; Comi LI; Nigro G; Angelini C; Nigro V
    J Med Genet; 2005 Sep; 42(9):686-93. PubMed ID: 16141003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis of calpain 3: advantages and limitations in diagnosing LGMD2A.
    Charlton R; Henderson M; Richards J; Hudson J; Straub V; Bushby K; Barresi R
    Neuromuscul Disord; 2009 Jul; 19(7):449-57. PubMed ID: 19556129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single c.1715G>C calpain 3 gene variant causes dominant calpainopathy with loss of calpain 3 expression and activity.
    Vissing J; Dahlqvist JR; Roudaut C; Poupiot J; Richard I; Duno M; Krag T
    Hum Mutat; 2020 Sep; 41(9):1507-1513. PubMed ID: 32557990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 550delA mutation in the calpain 3 (CAPN3) gene: DMD/BMD, SMA, or LGMD2A--clinically misdiagnosed cases.
    Georgieva B; Todorova A; Tournev I; Mitev V; Plageras P; Kremensky I
    Am J Med Genet A; 2005 Aug; 136A(4):399-400. PubMed ID: 16001438
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of a Novel Deep Intronic Mutation in CAPN3 Presenting a Promising Target for Therapeutic Splice Modulation.
    Hu Y; Mohassel P; Donkervoort S; Yun P; Bolduc V; Ezzo D; Dastgir J; Marshall JL; Lek M; MacArthur DG; Foley AR; Bönnemann CG
    J Neuromuscul Dis; 2019; 6(4):475-483. PubMed ID: 31498126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.